Wendy Diller

Senior Writer/Market Analyst

20 Years of Experience

About

Wendy writes on the medical devices and clinical diagnostics sectors, where she focuses on orthopedics/spine, molecular diagnostics and personalized medicine, clinical genomics, womens’ health/ femtech, and reimbursement/commercial strategy and innovation related to these specialties. She welcomes and encourages ideas and input from members of the MedTech Strategist Community.

Her career spans more than 20+ years as a top writer and manager focused on qualitative analysis of the global life sciences industry. She is Chair of Young Women in Bio Metro NY, an organization devoted to encouraging secondary students in the NY area to pursuit STEM careers and on the board of the Columbia Business School of Alumni Club NY

Specialties
Publications
Articles from Wendy Diller:
Read all from this author
Providers & Payors

Type 2 Diabetes, Dental, MSK Top US Healthcare Spending

  • 2025-05-28 00:00:00.0
  • Wendy Diller
  • MedTech Strategist

The first comprehensive, data-based analysis of US spending on healthcare by condition, an ongoing project of the Institute for Health Metrics and Evaluation at the University of Washington, aims to provide a more accurate assessment of US spending per disease, with potential to inform policy, industry, insurers, and other stakeholders. It concludes, to the surprise of some, we spend the most on type 2 diabetes, followed by musculoskeletal disorders and oral dental care.

Read Article